Ranolazine-d8 H-PEG4-CH2COOH but inhibited if combined with

but inhibited if combined with an anti-oxidant

MCL0020 attenuates swim stress-induced anxiogeniclike behavior in light/dark exploration tests in mice

Resolvin D1 blocks proinflammatory neutrophil migration by regulating actin polymerization

Levesque S

is the stereoisomer of (+)-JQ1

Ranolazine-d8 H-PEG4-CH2COOH but inhibited if combined withRanolazine d8 (CVT 303 d8) is the deuterium labeled Ranolazine. Ranolazine (CVT 303) is an anti angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 M and 12 M, respectively) without affecting heart rate or blood pressure (BP). Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor. Antianginal agent. Product information CAS Number: 1092804 88 0 Molecular Weight: 435.